Web based distress management for implantable cardioverter defibrillator patients: A randomized controlled trial

M. Habibovic, J. Denollet, P. Cuijpers, P.H. van der Voort, J.P. Herrman, L. Bouwels, Suzanne S. D. Valk, M. Alings, D.A. Theuns, S.S. Pedersen

Research output: Contribution to journalArticleScientificpeer-review

16 Citations (Scopus)

Abstract

Objective:
Sudden cardiac arrest caused by cardiac arrhythmias is 1 of the leading causes of death worldwide. Implantable cardioverter defibrillators (ICDs) are considered as standard care for patients with increased risk of arrhythmias. However, 1 in 4 ICD patients experiences psychological distress post-ICD implantation. The WEB-based distress management program for ICD patients (WEBCARE) was developed to mitigate anxiety and depression and enhance health-related quality of life in ICD patients. This study investigates the 6- and 12-months outcomes.
Method:
A total of 289 consecutive ICD patients from 6 referral hospitals in the Netherlands were randomized to either the WEBCARE (n = 146) or usual care (n = 143) group. Patients in the WEBCARE group received an online, 12-weeks fixed, 6 lesson behavioral treatment based on problem solving therapy. Patients in the usual care group receive care as usual.
Results:
Current findings show no significant difference on anxiety, depression or quality of life between the WEBCARE and Usual Care group at 6- and 12-months postimplantation.
Conclusions:
In this clinical trial of a Web-based behavioral intervention for ICD patients, the Web-based treatment was not superior to usual care on the long-term regarding patient reported outcomes. Future studies are warranted to examine the applicability of blended-care models and focus on further personalizing the program in order to increase adherence and improve outcomes.
Original languageEnglish
Pages (from-to)392-401
JournalHealth Psychology
Volume36
Issue number4
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'Web based distress management for implantable cardioverter defibrillator patients: A randomized controlled trial'. Together they form a unique fingerprint.

Cite this